Liver fibrosis worsens COVID-19 outcomes
In patients with metabolic dysfunction-associated fatty liver disease (MAFLD), liver fibrosis seems to worsen outcomes of the novel coronavirus disease (COVID-19), increasing the risk of mechanical ventilation, acute kidney injury, and death, a recent study has found.
